Locana is an RNA-targeting gene therapy company with a platform technology to address a wide spectrum of human genetic diseases. Locana has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting.
Market
Gene Therapy
Location
San Diego,
California,
USA
Coinvestors
ARCH Venture Partners, Google Ventures, Lightstone Ventures, Temasek, UC